Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 19, 2025
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
Vojtech Novohradsky, Tomer Babu, Hana Kostrhunova, et al.
Biochemical Pharmacology
|
April 3, 2007
DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]
Viktor Brabec, Petros Christofis, Martina Slámová, et al.
Journal of Inorganic Biochemistry
|
January 19, 2016
Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
Juraj Zajac, Hana Kostrhunova, Vojtech Novohradsky, et al.
Journal of Medicinal Chemistry
|
November 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models
Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová, et al.
Journal of Inorganic Biochemistry
|
July 27, 2014
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
Vojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Biochemical Pharmacology
|
April 19, 2015
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
Vojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Chemmedchem
|
February 17, 2017
Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its Pt<sup>IV</sup> Derivatives with Human Serum
Benjamin W J Harper, Aviva Friedman-Ezra, Roman Sirota, et al.
Chemical Science
|
July 13, 2018
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 21, 2012
Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design
Jenny Z Zhang, Paul Bonnitcha, Ezequiel Wexselblatt, et al.
Journal of Inorganic Biochemistry
|
February 2, 2008
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine
Anna Halámiková, Pavla Heringová, Jana Kaspárková, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 19, 2025
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
Vojtech Novohradsky, Tomer Babu, Hana Kostrhunova, et al.
Biochemical Pharmacology
|
April 3, 2007
DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]
Viktor Brabec, Petros Christofis, Martina Slámová, et al.
Journal of Inorganic Biochemistry
|
January 19, 2016
Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
Juraj Zajac, Hana Kostrhunova, Vojtech Novohradsky, et al.
Journal of Medicinal Chemistry
|
November 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models
Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová, et al.
Journal of Inorganic Biochemistry
|
July 27, 2014
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
Vojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Biochemical Pharmacology
|
April 19, 2015
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
Vojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Chemmedchem
|
February 17, 2017
Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its Pt<sup>IV</sup> Derivatives with Human Serum
Benjamin W J Harper, Aviva Friedman-Ezra, Roman Sirota, et al.
Chemical Science
|
July 13, 2018
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 21, 2012
Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design
Jenny Z Zhang, Paul Bonnitcha, Ezequiel Wexselblatt, et al.
Journal of Inorganic Biochemistry
|
February 2, 2008
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine
Anna Halámiková, Pavla Heringová, Jana Kaspárková, et al.
Page
of 9